The shares of Symbiotec Pharmalab IPO are commanding a strong premium of ₹270 in the grey market. The GMP of Symbiotec Pharmalab IPO is +270, according to Investorgain.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
